Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Illumina Inc
Illumina Inc
Activities:
Research & Development
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Almac expands sequencing capabilities through llumina instrument
Almac has purchased and installed an llumina NovaSeq X Plus instrument in Northern Ireland, which is set to expand its next generation sequencing capabilities for BioPharma partners
Regulatory
CMA challenges major genetic sequencing merger
The CMA has provisionally concluded that Illumina’s acquisition of Pacific Biosciences of California would result in a ‘substantial lessening of competition’
Research & Development
IDT partners with Illumina for NGS library preparation
Leaders in NGS tools collaborate to deliver robust multiplexing capabilities and streamline target enrichment methods
Research & Development
Almac to collaborate with Illumina on next-generation sequencing-based companion diagnostic development
The partnership with Illumina will provide an additional platform for the delivery of complex assays, expanding the options available to Almac partners
Design & Build
BioMed Realty and Illumina announce new build-to-suit laboratory building in Cambridge, UK
New state-of-the-art building to be located in scientific research park and will serve as Illumina's new European headquarters
Research & Development
Merck Serono and Illumina enter collaboration for diagnostics in oncology
Will develop assays that detect and measure multiple genetic variants in a single tumour sample to support clinical trials
Research & Development
Scotland to be at forefront of gene-led healthcare in £15m project with Illumina
Scottish Genomes Partnership will include Universities of Edinburgh and Glasgow
Subscribe now